Target and Pathway |
Top |
Target(s) |
Cyclin-dependent kinase 1 (CDK1) |
Target Info
|
Inhibitor |
[1] |
Cyclin-dependent kinase 2 (CDK2) |
Target Info
|
Inhibitor |
[1] |
Cyclin-dependent kinase 4 (CDK4) |
Target Info
|
Inhibitor |
[1] |
Cyclin-dependent kinase 6 (CDK6) |
Target Info
|
Inhibitor |
[1] |
Target's Patent Info |
Cyclin-dependent kinase 1 (CDK1) |
Target's Patent Info
|
[1] |
Cyclin-dependent kinase 2 (CDK2) |
Target's Patent Info
|
[1] |
Cyclin-dependent kinase 4 (CDK4) |
Target's Patent Info
|
[1] |
Cyclin-dependent kinase 6 (CDK6) |
Target's Patent Info
|
[1] |
KEGG Pathway
|
Cell cycle
|
Oocyte meiosis
|
p53 signaling pathway
|
Gap junction
|
Progesterone-mediated oocyte maturation
|
Herpes simplex infection
|
Epstein-Barr virus infection
|
Viral carcinogenesis
|
PI3K-Akt signaling pathway
|
Tight junction
|
T cell receptor signaling pathway
|
Hepatitis B
|
Measles
|
HTLV-I infection
|
Pathways in cancer
|
Pancreatic cancer
|
Glioma
|
Melanoma
|
Bladder cancer
|
Chronic myeloid leukemia
|
Small cell lung cancer
|
Non-small cell lung cancer
|
FoxO signaling pathway
|
Prostate cancer
|
MicroRNAs in cancer
|
NetPath Pathway
|
RANKL Signaling Pathway
|
TCR Signaling Pathway
|
EGFR1 Signaling Pathway
|
TGF_beta_Receptor Signaling Pathway
|
Panther Pathway
|
p53 pathway
|
p53 pathway feedback loops 2
|
Pathway Interaction Database
|
p73 transcription factor network
|
E2F transcription factor network
|
PLK1 signaling events
|
AP-1 transcription factor network
|
FOXM1 transcription factor network
|
Retinoic acid receptors-mediated signaling
|
Regulation of nuclear SMAD2/3 signaling
|
Calcineurin-regulated NFAT-dependent transcription in lymphocytes
|
Validated targets of C-MYC transcriptional activation
|
ATF-2 transcription factor network
|
Regulation of retinoblastoma protein
|
Signaling events mediated by PRL
|
ATR signaling pathway
|
mTOR signaling pathway
|
IL2-mediated signaling events
|
FoxO family signaling
|
BARD1 signaling events
|
p53 pathway
|
Coregulation of Androgen receptor activity
|
C-MYB transcription factor network
|
IL2 signaling events mediated by STAT5
|
Reactome
|
MAPK3 (ERK1) activation
|
E2F mediated regulation of DNA replication
|
G0 and Early G1
|
Cyclin B2 mediated events
|
Golgi Cisternae Pericentriolar Stack Reorganization
|
Cdc20:Phospho-APC/C mediated degradation of Cyclin A
|
Regulation of APC/C activators between G1/S and early anaphase
|
Phosphorylation of the APC/C
|
Phosphorylation of Emi1
|
Condensation of Prophase Chromosomes
|
MASTL Facilitates Mitotic Progression
|
Resolution of Sister Chromatid Cohesion
|
Condensation of Prometaphase Chromosomes
|
Regulation of PLK1 Activity at G2/M Transition
|
Activation of NIMA Kinases NEK9, NEK6, NEK7
|
Loss of Nlp from mitotic centrosomes
|
Recruitment of mitotic centrosome proteins and complexes
|
Loss of proteins required for interphase microtubule organization?from the centrosome
|
Recruitment of NuMA to mitotic centrosomes
|
Depolymerisation of the Nuclear Lamina
|
Anchoring of the basal body to the plasma membrane
|
MAPK6/MAPK4 signaling
|
G1/S-Specific Transcription
|
Cyclin A/B1 associated events during G2/M transition
|
G2/M DNA replication checkpoint
|
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
|
Oxidative Stress Induced Senescence
|
Senescence-Associated Secretory Phenotype (SASP)
|
Oncogene Induced Senescence
|
RMTs methylate histone arginines
|
Transcriptional regulation of white adipocyte differentiation
|
Ubiquitin-dependent degradation of Cyclin D1
|
Cyclin D associated events in G1
|
Meiotic recombination
|
Activation of ATR in response to replication stress
|
SCF(Skp2)-mediated degradation of p27/p21
|
DNA Damage/Telomere Stress Induced Senescence
|
Processing of DNA double-strand break ends
|
G2 Phase
|
Orc1 removal from chromatin
|
Cyclin E associated events during G1/S transition
|
p53-Dependent G1 DNA Damage Response
|
Cyclin A:Cdk2-associated events at S phase entry
|
Factors involved in megakaryocyte development and platelet production
|
WikiPathways
|
DNA Damage Response
|
G1 to S cell cycle control
|
TGF beta Signaling Pathway
|
PPAR Alpha Pathway
|
MAP kinase activation in TLR cascade
|
RAF/MAP kinase cascade
|
Mitotic Prophase
|
Mitotic Prometaphase
|
BMI1
|
ATM Signaling Pathway
|
Retinoblastoma (RB) in Cancer
|
Spinal Cord Injury
|
Prostate Cancer
|
Regulation of Microtubule Cytoskeleton
|
Integrated Cancer pathway
|
Mitotic G2-G2/M phases
|
Mitotic G1-G1/S phases
|
Cell Cycle
|
APC/C-mediated degradation of cell cycle proteins
|
Cell Cycle Checkpoints
|
miRNA Regulation of DNA Damage Response
|
Ovarian Infertility Genes
|
Bladder Cancer
|
S Phase
|
Transcriptional Regulation of White Adipocyte Differentiation
|
Meiotic Recombination
|
Integrated Pancreatic Cancer Pathway
|
Signaling Pathways in Glioblastoma
|
TSH signaling pathway
|
Integrated Breast Cancer Pathway
|
ID signaling pathway
|
DNA Replication
|
M/G1 Transition
|
Aryl Hydrocarbon Receptor
|
Oncostatin M Signaling Pathway
|
Synthesis of DNA
|
Regulation of DNA replication
|
Factors involved in megakaryocyte development and platelet production
|
Wnt Signaling Pathway Netpath
|
Metastatic brain tumor
|
miR-targeted genes in muscle cell - TarBase
|
miR-targeted genes in lymphocytes - TarBase
|
miR-targeted genes in leukocytes - TarBase
|
miR-targeted genes in epithelium - TarBase
|
miRNAs involved in DNA damage response
|